(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Targeted disruption of FM2 enhancer. (A) Diagrammatic representation of
wild-type Otx2 allele, targeting vector and recombinant allele. The
black box indicates the BsmI-BamHI 1.0 kb region (FM2) to be
replaced with a neomycin-resistant gene (Neo) (see
Fig. 3A for others). (B)
Otx2
FM2/
FM2 (a,b) and
Otx2
FM2/ (c,d) phenotype at E12.5 (a,c) and
E15.5 (b,d). The phenotypes were examined with both the
Otx2
FM2 mutant in which the neo insert remained and
the Otx2
FM2 mutant in which the insert was deleted
by Cre recombination. No differences were found, and the following, marker
analyses were performed with the mutant that retained the neo insert.
(C) Marker analysis of Otx2
FM2/ phenotype at
E10.5; Otx2 (a), Pax6 (b), Fgf8 (c) and
Emx2 (d) expression (see Fig.
3C for the expression in wild-type embryos). Scale bars: 400
µm.